Clinical Trial Update: Effects of Ondansetron on Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus and Dyspepsia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effects of ondansetron on gastrointestinal sensorimotor dysfunction in diabetes mellitus and dyspepsia; currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Dyspepsia

Drugs mentioned

• Ondansetron (Zofran) (ondansetron)

Snippet

Sponsor: Mayo Clinic | Conditions: Indigestion, Diabetes Mellitus | Phase 2 | Status: RECRUITING